Pre-Treatment Tumor Growth Rate (TGR0) in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs) Treated with Systemic Therapies: Subgroup Analysis of the GREPONET Study
Crona J, Lamarca A, Ronot M, Opalinska M, Lopez Lopez C, Pezzutti D, Vidal Trueba H, Carvhalo L, De Mestier L, Najran P, Pavel ME, Dromain C (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Book Volume: 106
Pages Range: 171-171
Authors with CRIS profile
Involved external institutions
Marqués de Valdecilla University Hospital / Hospital Universitario de Marqués de Valdecilla (HUMV)
Spain (ES)
Christie NHS Foundation Trust
United Kingdom (GB)
Lausanne University Hospital / Centre hospitalier universitaire vaudois (CHUV)
Switzerland (CH)
Beaujon Hospital / Hôpital Beaujon
France (FR)
The University Hospital in Krakow
Poland (PL)
Uppsala University
Sweden (SE)
Hospital Israelita Albert Einstein
Brazil (BR)
Hospital Sírio-Libanês
Brazil (BR)
Spain (ES)
Christie NHS Foundation Trust
United Kingdom (GB)
Lausanne University Hospital / Centre hospitalier universitaire vaudois (CHUV)
Switzerland (CH)
Beaujon Hospital / Hôpital Beaujon
France (FR)
The University Hospital in Krakow
Poland (PL)
Uppsala University
Sweden (SE)
Hospital Israelita Albert Einstein
Brazil (BR)
Hospital Sírio-Libanês
Brazil (BR)
How to cite
APA:
Crona, J., Lamarca, A., Ronot, M., Opalinska, M., Lopez Lopez, C., Pezzutti, D.,... Dromain, C. (2018). Pre-Treatment Tumor Growth Rate (TGR0) in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs) Treated with Systemic Therapies: Subgroup Analysis of the GREPONET Study. (pp. 171-171).
MLA:
Crona, J., et al. "Pre-Treatment Tumor Growth Rate (TGR0) in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs) Treated with Systemic Therapies: Subgroup Analysis of the GREPONET Study." 2018. 171-171.
BibTeX: Download